AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33044710 — intervention group
Group type: COMPARATOR
Intervention: 15 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450
Study 33044710 — intervention group
Group type: COMPARATOR
Intervention: 75 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450
Study 33044710 — intervention group
Group type: COMPARATOR
Intervention: 150 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450
Study 33044710 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg Cu/kg as Cu-Lys-Glu
Number of subjects: 450
Study 33044710 — intervention group
Group type: COMPARATOR
Intervention: 0 mg Cu/kg as Cu-Lys-Glu (control)
Number of subjects: 450
Study 33149729 — intervention group
Group type: EXPERIMENTAL
Intervention: Short hemostasis (3 hours)
Number of subjects: 1000
Study 33149729 — intervention group
Group type: COMPARATOR
Intervention: Prolonged hemostasis (8 hours)
Number of subjects: 1000
Study 33149729 — intervention group
Group type: EXPERIMENTAL
Intervention: Rescue recanalization (only in short hemostasis group)
Number of subjects: 1000
Study 35296044 — intervention group
Group type: EXPERIMENTAL
Intervention: ECE‐based nutrition and gardening curriculum; nutrition education and food sovereignty curriculum for adults; ECE program menu modifications
Number of subjects: 168
Study 35296044 — intervention group
Group type: COMPARATOR
Intervention: Control group (wait-list)
Number of subjects: 168
Study 35296044 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 168
Study 36429931 — intervention group
Group type: EXPERIMENTAL
Intervention: Elastic Foot Orthosis (EFO)
Number of subjects: 21
Study 36429931 — intervention group
Group type: COMPARATOR
Intervention: Sham Foot Orthosis (SFO)
Number of subjects: 21
Study 34262967 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 91
Study 34262967 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 91
Study 34262967 — intervention group
Group type: COMPARATOR
Intervention: Group Walking (GW)
Number of subjects: 91
Study 32993831 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted trauma-focused CBT-based guided self-help (CatCBT GSH) in nine sessions over 12 weeks
Number of subjects: 50
Study 32993831 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 50
Study 32901234 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration with Icon (RI; DMG)
Number of subjects: 15
Study 32901234 — intervention group
Group type: EXPERIMENTAL
Intervention: Remin Pro (RP; VOCO)
Number of subjects: 15
Study 32901234 — intervention group
Group type: COMPARATOR
Intervention: Complete Care toothpaste (CC; Himalaya)
Number of subjects: 15
Study 36259302 — intervention group
Group type: EXPERIMENTAL
Intervention: Equicrestal placement of dental implants (Group I)
Number of subjects: 40
Study 36259302 — intervention group
Group type: COMPARATOR
Intervention: Subcrestal placement of dental implants (Group II)
Number of subjects: 40
Study 32367375 — intervention group
Group type: EXPERIMENTAL
Intervention: OPEN (conventional open suture)
Number of subjects: 90
Study 32367375 — intervention group
Group type: EXPERIMENTAL
Intervention: MIN (minimally invasive suture)
Number of subjects: 90
Study 32367375 — intervention group
Group type: COMPARATOR
Intervention: CONS (conservative treatment)
Number of subjects: 90
Study 32367375 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education curriculum as a core subject
Number of subjects: 80
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in teaching nutrition
Number of subjects: 80
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Adequate nutrition curricular materials
Number of subjects: 80
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on nutrition education
Number of subjects: 80
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Confidence in students' interest in nutrition
Number of subjects: 80
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of nutrition education on dietary behaviour
Number of subjects: 80
Study 32141594 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of interest and confidence between subjects taught
Number of subjects: 80
Study 33181730 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicated honey dressing
Number of subjects: 99
Study 33181730 — intervention group
Group type: COMPARATOR
Intervention: Standard care (routine wound care)
Number of subjects: 99
Study 35562290 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral appliance therapy
Number of subjects: 314
Study 32720552 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment (3 treatments at monthly intervals)
Number of subjects: 30
Study 32720552 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting (no treatment)
Number of subjects: 30
Study 32720552 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment
Number of subjects: 30
Study 32720552 — intervention group
Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 30
Study 36012990 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day fasting followed by 10 weeks of lifestyle modification
Number of subjects: 145
Study 36012990 — intervention group
Group type: COMPARATOR
Intervention: 10 weeks of lifestyle modification only
Number of subjects: 145
Study 36494723 — intervention group
Group type: EXPERIMENTAL
Intervention: MOHMQuit intervention
Number of subjects: 4000
Study 34385236 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care (PoC) testing and immediate treatment of curable STIs
Number of subjects: 0
Study 34385236 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care
Number of subjects: 0
Study 32954487 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg/day of pharmaceutical-grade chondroitin sulfate (CS)
Number of subjects: 0
Study 32954487 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32954487 — intervention group
Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 0
Study 33926446 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine U300 (IGlar‐300)
Number of subjects: 23
Study 33926446 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin degludec U100 (IDeg‐100)
Number of subjects: 23
Study 33046094 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicines and Alcohol Consultation (MAC) delivered by trained community pharmacists (n=5) during Medicine Use Review (MUR) and New Medicine Service (NMS) consultations.
Number of subjects: 260
Study 33046094 — intervention group
Group type: COMPARATOR
Intervention: Control group provided usual MUR/NMS services without the MAC intervention (n=5).
Number of subjects: 260
Study 35164805 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention with a Viral Prescription Pad and emphasis on harms of antibiotics (OH Trial)
Number of subjects: 0
Study 35164805 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and feedback intervention with variations (PHO Trial)
Number of subjects: 0
Study 35164805 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving the intervention)
Number of subjects: 0
Study 32660932 — intervention group
Group type: EXPERIMENTAL
Intervention: Cue utilisation assessment prior to the rail control task
Number of subjects: 55
Study 32660932 — intervention group
Group type: EXPERIMENTAL
Intervention: Situational awareness assessed using SAGAT queries during the rail control task
Number of subjects: 55
Study 32660932 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated rail control task under varying task demands
Number of subjects: 55
Study 36002548 — intervention group
Group type: EXPERIMENTAL
Intervention: 1250 mg of β-nicotinamide mononucleotide (β-NMN) administered orally once daily for up to 4 weeks
Number of subjects: 31
Study 36002548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 34290065 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-invasive vagus nerve stimulation (nVNS)
Number of subjects: 140
Study 32106827 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic training in the use of the Guide to Action Tool for Care Homes
Number of subjects: 6
Study 32106827 — intervention group
Group type: COMPARATOR
Intervention: New falls prevention initiatives implemented outside the study
Number of subjects: 6
Study 616782726 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over left dorsolateral prefrontal cortex, 20 minutes, 2 mA, for 10 sessions
Number of subjects: 44
Study 616782726 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 44
Study 35278903 — intervention group
Group type: EXPERIMENTAL
Intervention: Ficus septica exudate
Number of subjects: 150
Study 35278903 — intervention group
Group type: COMPARATOR
Intervention: Savlon antiseptic cream
Number of subjects: 150
Study 35278903 — intervention group
Group type: COMPARATOR
Intervention: Soap and water treatment
Number of subjects: 150
Study 33444781 — intervention group
Group type: EXPERIMENTAL
Intervention: CVRS (Cardiovascular Risk Service) provided by remote clinical pharmacists
Number of subjects: 325
Study 33444781 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 325
Study 33175326 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure Portland cement
Number of subjects: 136
Study 33175326 — intervention group
Group type: COMPARATOR
Intervention: Formocresol
Number of subjects: 136
Study 33049713 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-protein risk signature developed from the discovery cohort.
Number of subjects: 0
Study 33049713 — intervention group
Group type: EXPERIMENTAL
Intervention: HER3_pY1289 staining intensity.
Number of subjects: 0
Study 33049713 — intervention group
Group type: EXPERIMENTAL
Intervention: HER3 suppression.
Number of subjects: 0
Study 36113531 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of Cervarix
Number of subjects: 930
Study 36113531 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of Cervarix
Number of subjects: 930
Study 36113531 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of Cervarix
Number of subjects: 930
Study 36113531 — intervention group
Group type: EXPERIMENTAL
Intervention: One dose of Gardasil-9
Number of subjects: 930
Study 36113531 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of Gardasil-9
Number of subjects: 930
Study 36113531 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of Gardasil-9
Number of subjects: 930
Study 36113531 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 930
Study 33626501 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam roller for 30 seconds
Number of subjects: 40
Study 33626501 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam roller for 2 minutes
Number of subjects: 40
Study 33072214 — intervention group
Group type: EXPERIMENTAL
Intervention: ProTaper Universal files (Dentsply Maillefer) used in rotary preparation
Number of subjects: 50
Study 33072214 — intervention group
Group type: EXPERIMENTAL
Intervention: Failures during rotary preparation
Number of subjects: 50
Study 35501569 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic relaxation and sexual counseling based on the IMB model (4 sessions)
Number of subjects: 34
Study 35501569 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment protocol (Control)
Number of subjects: 34
Study 33271509 — intervention group
Group type: EXPERIMENTAL
Intervention: Moral intervention
Number of subjects: 303
Study 33271509 — intervention group
Group type: COMPARATOR
Intervention: Educational intervention
Number of subjects: 303
Study 32603336 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic techniques (thoracic thrust, sternal pump technique, diaphragm stretching)
Number of subjects: 30
Study 32603336 — intervention group
Group type: COMPARATOR
Intervention: Soft tissue therapy (STT) techniques for the masseter muscle
Number of subjects: 30
Study 35723225 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy (metformin/pioglitazone/exenatide)
Number of subjects: 46
Study 35723225 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (metformin/insulin/glipizide)
Number of subjects: 46
Study 33276817 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupotomy combined with PCA
Number of subjects: 70
Study 33276817 — intervention group
Group type: COMPARATOR
Intervention: Conventional PCA
Number of subjects: 70
Study 32773637 — intervention group
Group type: EXPERIMENTAL
Intervention: ESRT (Enhanced Stress Resilience Training)
Number of subjects: 89
Study 32773637 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 89
Study 35605867 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-day pulse delivery of glyphosate (Rodeo)
Number of subjects: 7
Study 35605867 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous delivery of glyphosate (Rodeo)
Number of subjects: 7
Study 35605867 — intervention group
Group type: COMPARATOR
Intervention: Both pulse and continuous delivery methods
Number of subjects: 7
Study 35605867 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive samplers (POCIS-MIP)
Number of subjects: 7
Study 34684508 — intervention group
Group type: EXPERIMENTAL
Intervention: Swank diet
Number of subjects: 0
Study 34684508 — intervention group
Group type: EXPERIMENTAL
Intervention: Wahls diet
Number of subjects: 0
Study 34684508 — intervention group
Group type: EXPERIMENTAL
Intervention: Wahls diet (including supplements)
Number of subjects: 0
Study 34684508 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets (including supplements)
Number of subjects: 0
Study 35538539 — intervention group
Group type: EXPERIMENTAL
Intervention: Tanimilast
Number of subjects: 0
Study 35538539 — intervention group
Group type: COMPARATOR
Intervention: Budesonide
Number of subjects: 0
Study 33308325 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model (2 CT signs and 2 texture parameters)
Number of subjects: 172
Study 33308325 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical model
Number of subjects: 172
Study 33308325 — intervention group
Group type: EXPERIMENTAL
Intervention: CT model
Number of subjects: 172
Study 33308325 — intervention group
Group type: EXPERIMENTAL
Intervention: Texture model
Number of subjects: 172
Study 36074965 — intervention group
Group type: EXPERIMENTAL
Intervention: Blessed TRI 360TM capsule (Biofield Energy Treated Proprietary Dietary Supplement) taken twice a day (morning and evening)
Number of subjects: 77
Study 36074965 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (no treatment/capsule)
Number of subjects: 77
Study 36074965 — intervention group
Group type: EXPERIMENTAL
Intervention: Blessed TRI 360TM capsule
Number of subjects: 77
Study 33215362 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Calorie Ketogenic Diet (LCKD)
Number of subjects: 48
Study 33215362 — intervention group
Group type: COMPARATOR
Intervention: Standard Low-Calorie Diet (LCD)
Number of subjects: 48
Study 33705355 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,000 IU daily vitamin D3 supplementation
Number of subjects: 69
Study 33705355 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,000 IU daily vitamin D3 supplementation
Number of subjects: 69
Study 33705355 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 69
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA and 2% CHX
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% maleic acid (MA)
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% MA and 2% CHX
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: 5.25% NaOCl
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: AH Plus
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoREZ
Number of subjects: 160
Study 34737843 — intervention group
Group type: EXPERIMENTAL
Intervention: Tech BioSealer Endo
Number of subjects: 160
Study 36396999 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg L-1 SiO2-NPs
Number of subjects: 2
Study 36396999 — intervention group
Group type: EXPERIMENTAL
Intervention: SiO2-NPs treatment
Number of subjects: 2
Study 36396999 — intervention group
Group type: COMPARATOR
Intervention: Drought stress (control)
Number of subjects: 2
Study 33737088 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute exercise (30 minutes)
Number of subjects: 20
Study 33737088 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 20
Study 36524101 — intervention group
Group type: EXPERIMENTAL
Intervention: Leriglitazone
Number of subjects: 39
Study 36524101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 34811384 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly interactive text messages asking 'How are you?' until 24 months postpartum.
Number of subjects: 600
Study 34811384 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving routine PMTCT care without text messages.
Number of subjects: 600
Study 33895468 — intervention group
Group type: EXPERIMENTAL
Intervention: Stair walking
Number of subjects: 29
Study 33895468 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 29
Study 33895468 — intervention group
Group type: EXPERIMENTAL
Intervention: RFID devices
Number of subjects: 29
Study 33895468 — intervention group
Group type: EXPERIMENTAL
Intervention: Bluetooth and RFID readers
Number of subjects: 29
Study 34097130 — intervention group
Group type: EXPERIMENTAL
Intervention: normobaric hypoxia (13% FiO2) + NO3- (HNO)
Number of subjects: 30
Study 34097130 — intervention group
Group type: EXPERIMENTAL
Intervention: normobaric hypoxia + placebo (HPL)
Number of subjects: 30
Study 34097130 — intervention group
Group type: COMPARATOR
Intervention: normoxia (20.9% FiO2) + placebo (CON)
Number of subjects: 30
Study 34097130 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated-sprint training (RSH)
Number of subjects: 30
Study 32559503 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain reduction
Number of subjects: 309
Study 32559503 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic and clinical factors
Number of subjects: 309
Study 32559503 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariates (treatment group, time, baseline depression severity)
Number of subjects: 309
Study 36107611 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES)
Number of subjects: 24
Study 36107611 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 24
Study 36107611 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 24
Study 34016453 — intervention group
Group type: EXPERIMENTAL
Intervention: cTC + bevacizumab
Number of subjects: 122
Study 34016453 — intervention group
Group type: EXPERIMENTAL
Intervention: ddTC + bevacizumab
Number of subjects: 122
Study 34016453 — intervention group
Group type: COMPARATOR
Intervention: cTC
Number of subjects: 122
Study 34016453 — intervention group
Group type: COMPARATOR
Intervention: ddTC
Number of subjects: 122
Study 34162699 — intervention group
Group type: EXPERIMENTAL
Intervention: BeSMART intervention
Number of subjects: 225
Study 34162699 — intervention group
Group type: EXPERIMENTAL
Intervention: BeSMART + physician review
Number of subjects: 225
Study 34162699 — intervention group
Group type: COMPARATOR
Intervention: Control (tobacco smoke videos and handouts)
Number of subjects: 225
Study 34826125 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (CoQ10) supplementation for 4 months
Number of subjects: 39
Study 34826125 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 34162720 — intervention group
Group type: EXPERIMENTAL
Intervention: Dixon fat‐water imaging (quantitative fat‐water MRI)
Number of subjects: 24
Study 32289676 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibitory rTMS (continuous theta-burst stimulation paradigm at 50 Hz for 40s)
Number of subjects: 52
Study 32289676 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 52
Study 36089529 — intervention group
Group type: EXPERIMENTAL
Intervention: Darolutamide 600 mg twice daily
Number of subjects: 1509
Study 36089529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1509
Study 33185847 — intervention group
Group type: EXPERIMENTAL
Intervention: da Vinci training simulator (group 1)
Number of subjects: 25
Study 33185847 — intervention group
Group type: EXPERIMENTAL
Intervention: computer‐based cognitive training (group 2)
Number of subjects: 25
Study 33185847 — intervention group
Group type: COMPARATOR
Intervention: Control group without training (group 3)
Number of subjects: 25
Study 32729275 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-coated balloon angioplasty (DBA)
Number of subjects: 39
Study 32729275 — intervention group
Group type: COMPARATOR
Intervention: Plain balloon angioplasty (PBA)
Number of subjects: 39
Study 36513447 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-based formula (group A: protein 20%, olive and sunflower oil 45%, carbohydrate 35%)
Number of subjects: 93
Study 36513447 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-based formula (group A)
Number of subjects: 93
Study 36513447 — intervention group
Group type: COMPARATOR
Intervention: Control group (carbohydrate-based formula: protein 20%, fat 30%, carbohydrate 50%)
Number of subjects: 93
Study 36513447 — intervention group
Group type: COMPARATOR
Intervention: Control group and group B
Number of subjects: 93
Study 36513447 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 93
Study 32966683 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 g/d of mixed nuts (nut group)
Number of subjects: 72
Study 32966683 — intervention group
Group type: COMPARATOR
Intervention: Usual Western-style diet avoiding consumption of nuts (control group)
Number of subjects: 72
Study 32210455 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream (1 g, 25 mg lidocaine + 25 mg prilocaine applied 1 hour prior to puncture)
Number of subjects: 66
Study 32210455 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine tape (one sheet, 18 mg lidocaine applied 30 minutes prior to puncture)
Number of subjects: 66
Study 33583033 — intervention group
Group type: EXPERIMENTAL
Intervention: NAFLD
Number of subjects: 0